Thrombosis Flashcards
RF for thrombosis in children
- Central line - Cancer - surgery - Sepsis/unwell child - trauma/immobility - obesity - estrogen - dehydration - anti-phosphiolipid syndrome - chronic disease (cardiac, rheum, IBD)
RF for ARTERIAL clots
AIS - cardiogenic - vasculopathy (moyamoya) - in situ thrombosis (unwell child with iron def, hyperhomocystenemia) Catheter - umbilical, femoral Perinatal stroke
What types of thrombosis are you at risk for with estrogen based OCP
VTE stroke MI 4-fold increase in risk. Note absolute risk is low so most have additional RF
Initial labs for patient with new clot
CBC INR/PTT fibrinogen Creatinine d-dimer and FVIII - not specific but if elevated and persistent, then predictive of poor outcome
Describe May Thurner syndrome
Right iliac artery crosses over left iliac vein - chronic narrowing of vein
When to evaluate for hypercoagulable state
- non CVL thrombosis - Recurrent thrombosis - Contraception councelling in adolescent with strong family history
Hypercoag workup
- APC resistance (FVL, Prothrombin gene mutation) - Protein C - Protein S - AT - Hyperhomocystenemia - Elevated FVIII - lipoprotein a - dysfibrinogenemia - PAI-1 def - Anti-phospholipid antibodies
Factor V Leiden key points
Mechanism: APC resistance - 95% heterozygotes never have VTE - 4x increased risk for hetero, - 80x for homozygotes. –> Absolute risk is tiny for children - no risk of arterial clots
Which severe thrombophilia is notable for pregnancy-related VTE
anti-thrombin deficiency (heterozygous)
Neonate with pulpura fulminans
Protein C/S deficiency (homozygous) Manage: aggressive FFP Q12h, lifelong anti-coagulation
Age-related changes in Protein C/S and AT
- all low as neonate - Protein S at adult level at 6-12 m - Protein C remains low till late teens
Anti-phospholipid syndrome diagnosis
Clinical (at least 1): - venous or arterial thrombosis - recurrent preg loss < 10 wk GA, or prem < 34 wks due to pre-eclampsia/placental insuff Lab criteria (at least 1): - Persistent LA, ACL, or B2Glycoprotein antibody for > 12wks with context of acute thrombosis Catastrophic APS - 3 or more clots in 1 week.
Heparin mechanism of action
Binds AT and increases activity by 1000x - inactivated thrombin and FXa
Name anticoag & mech of action other than heparin/LMWH/warfarin
Xa inhibitors: - Fondaparinux (IV) - Danaparoid (IV) - Rivaroxaban (oral) - Apixaban (oral) - Edoxaban (oral) Thrombin inhibitor: - Argatroban (IV) - Bivilarudin (IV) - Dabigatran (oral)
Reasons for heparin resistance
- using PTT rather than Xa (false resistance) –> high fibrinogen/FVIII in inflammation will normalize PTT even if Xa is therapeutic - AT deficiency (cong or acquired ex. asparaginase) - Increased clearance (Lasix, CVH) - Increased heparin binding proteins